Boddingtons Gives Fast Response to the COVID-19 Call

Medical device manufacturer, Boddingtons, has lately been resourcing fast-tooling and moulding projects in relation to emergency procurement for the COVID-19 crisis.

“Some lines of enquiry in the past three weeks have been unrealistic and unworkable,” notes Boddingtons CEO Andy Tibbs, “but others – such as our latest project for filter housings for a COVID-19 face mask – have involved around the clock design, fast tooling and moulding in order to get into the medical frontline.”

Kent-based Boddingtons has geared its engineering resources and production capabilities to help meet the current threat of the Coronavirus, turning drawings to products in less than two weeks, which included the manufacture of mould tooling to support.

Every morning at 7:00 am, Tibbs chairs a three-person council of Operations, Sales and Finance functions in order to meet existing manufacturing obligations and to try and factor in new enquiries such as the innovative COVID-19 mask filter housings.

Andy Tibbs added, “Projects designed for our recently expanded Class 7 cleanroom would normally take months and years to fully design develop into full production. COVID-19 will change all of that. We expect a batch of consequences to not only reshape the future of medical devices and technology but also to be mindful of shortening the supply chain; reshoring vital med-tech manufacturing back to the UK.”

Recent investments at Boddingtons – in Class 7 cleanroom expansions; in the Mitutoyo Quick Vision Active CMM machine and in the universal MDSAP medical quality qualification – will all enable the speedy introduction of medical manufacturing.

The company’s award-winning design expertise for medical devices has been recognised on a near-annual basis over the past six years. Medical and healthcare clients include SME start-ups and Medical OEMs.

Contact Boddingtons direct for manufacturing needs in relation to the virus. Telephone 01622 833723.

Boddingtons logo
+44 (0)1622 833700

Subscribe to our newsletter